CME Group Inc. (CME) vs Schwab U.S. Dividend Equity ETF (SCHD)
Over the past 10 years, CME outperformed SCHD — 14.16% vs 12.63% annualized total return (price plus dividends).
A side-by-side comparison of CME Group Inc. and Schwab U.S. Dividend Equity ETF across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
Total return — CME vs SCHD
growth of $100 · dividends reinvested · last 15yMetrics side by side
Did CME beat SCHD?
Over the past 10 years, CME outperformed SCHD — 14.16% vs 12.63% annualized total return (price plus dividends).
Total return (annualized)
| Metric | CME | SCHD |
|---|---|---|
| Total return (1Y) | -2.38% | 30.94% |
| Total return CAGR (3Y) | 14.33% | 14.01% |
| Total return CAGR (5Y) | 8.74% | 9.54% |
| Total return CAGR (10Y) | 14.16% | 12.63% |
SCHD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has CME beaten SCHD?
- Over the past 10 years, CME outperformed SCHD — 14.16% vs 12.63% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.